We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Tm Bioscience to Supply PathGroup with Tag-It™ Reagents
News

Tm Bioscience to Supply PathGroup with Tag-It™ Reagents

Tm Bioscience to Supply PathGroup with Tag-It™ Reagents
News

Tm Bioscience to Supply PathGroup with Tag-It™ Reagents

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Tm Bioscience to Supply PathGroup with Tag-It™ Reagents"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Tm Bioscience Corporation has announced it has signed an agreement to supply PathGroup (Brentwood, Tennessee) with the Tag-It™ ASRx reagents for use in its Cystic Fibrosis gene assay.

“We are committed to providing the highest quality medical diagnostic services available, serving patients across Tennessee, Kentucky, Indiana, Illinois, North Carolina, and Georgia,” said Dr. Safedin Beqaj, Laboratory Director, Microbiology and Molecular Diagnostics, PathGroup Labs.

“Using the reagents from Tm Bioscience, we have developed an upgraded CF assay that performs to our high standards and reduces operator time significantly, which will enable PathGroup to address the growing demand for Cystic Fibrosis screening and best serve our customers.”

“We are pleased that PathGroup, a leading provider of diagnostics services for the southeast and lower midwest United States, has selected products from Tm Bioscience and adopted our standardized Tag-It™ approach,” said Greg Hines, President and CEO of Tm Bioscience.

“We look forward to working with Dr. Beqaj to evaluate additional products from our menu.”

Advertisement